Drinkall Samuel, Lawrence Catherine B, Ossola Bernadino, Russell Samuel, Bender Clare, Brice Nicola B, Dawson Lee A, Harte Michael, Brough David
Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Glia. 2022 Jul;70(7):1301-1316. doi: 10.1002/glia.24174. Epub 2022 Mar 30.
The NLRP3 (NLR family, pyrin domain containing 3) inflammasome is a multi-protein complex responsible for the activation of caspase-1 and the subsequent cleavage and activation of the potent proinflammatory cytokines IL-1β and IL-18, and pyroptotic cell death. NLRP3 is implicated as a driver of inflammation in a range of disorders including neurodegenerative diseases, type 2 diabetes, and atherosclerosis. A commonly reported mechanism contributing to NLRP3 inflammasome activation is potassium ion (K ) efflux across the plasma membrane. Identification of K channels involved in NLRP3 activation remains incomplete. Here, we investigated the role of the K channel THIK-1 in NLRP3 activation. Both pharmacological inhibitors and cells from THIK-1 knockout (KO) mice were used to assess THIK-1 contribution to macrophage NLRP3 activation in vitro. Pharmacological inhibition of THIK-1 inhibited caspase-1 activation and IL-1β release from mouse bone-marrow-derived macrophages (BMDMs), mixed glia, and microglia in response to NLRP3 agonists. Similarly, BMDMs and microglia from THIK-1 KO mice had reduced NLRP3-dependent IL-1β release in response to P2X7 receptor activation with ATP. Overall, these data suggest that THIK-1 is a regulator of NLRP3 inflammasome activation in response to ATP and identify THIK-1 as a potential therapeutic target for inflammatory disease.
NLRP3(含pyrin结构域的NLR家族成员3)炎性小体是一种多蛋白复合物,负责激活半胱天冬酶-1以及随后切割和激活强效促炎细胞因子IL-1β和IL-18,并导致细胞焦亡。NLRP3被认为是包括神经退行性疾病、2型糖尿病和动脉粥样硬化在内的一系列疾病中炎症的驱动因素。一种常见的导致NLRP3炎性小体激活的机制是钾离子(K⁺)跨质膜外流。参与NLRP3激活的钾通道的鉴定仍不完整。在此,我们研究了钾通道THIK-1在NLRP3激活中的作用。使用药理学抑制剂和来自THIK-1基因敲除(KO)小鼠的细胞来评估THIK-1在体外对巨噬细胞NLRP3激活的作用。对THIK-1的药理学抑制可抑制小鼠骨髓来源的巨噬细胞(BMDM)、混合神经胶质细胞和小胶质细胞在响应NLRP3激动剂时半胱天冬酶-1的激活和IL-1β的释放。同样,来自THIK-1 KO小鼠的BMDM和小胶质细胞在使用ATP激活P2X7受体时,NLRP3依赖性IL-1β的释放减少。总体而言,这些数据表明THIK-1是响应ATP时NLRP3炎性小体激活的调节因子,并将THIK-1确定为炎性疾病的潜在治疗靶点。